Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 12.32 CNY -1.91%
Market Cap: 10.2B CNY
Have any thoughts about
Yantai Dongcheng Biochemicals Co Ltd?
Write Note
Yantai Dongcheng Biochemicals Co Ltd
/
Balance Sheet
/
Additional Paid In Capital

Yantai Dongcheng Biochemicals Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Yantai Dongcheng Biochemicals Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Additional Paid In Capital
¥2B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
13%
Beigene Ltd
HKEX:6160
Additional Paid In Capital
¥81.4B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Additional Paid In Capital
¥27.5B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Additional Paid In Capital
¥3.3B
CAGR 3-Years
95%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Additional Paid In Capital
¥3.5B
CAGR 3-Years
-1%
CAGR 5-Years
90%
CAGR 10-Years
N/A
No Stocks Found

Yantai Dongcheng Biochemicals Co Ltd
Glance View

Market Cap
10.2B CNY
Industry
Biotechnology

In the bustling industrial city of Yantai, nestled along China's northeastern coast, Yantai Dongcheng Biochemicals Co Ltd has emerged as a formidable entity in the global biopharmaceutical landscape. Founded in 1998, the company has cleverly positioned itself at the confluence of modern science and traditional Chinese medicine. The hallmark of Dongcheng's business is its sophisticated production of active pharmaceutical ingredients (APIs), particularly heparin, which has earned it a prominent spot on the world stage. Through its agile manufacturing processes and commitment to quality, the company deftly navigates the intricate web of pharmaceutical demands, supplying essential components to global drug manufacturers who trust Dongcheng's expertise to ensure efficacy and safety in their final products. The financial engine of Yantai Dongcheng Biochemicals is powered by its vertically integrated model, which extends from raw material acquisition to finished product delivery. This strategic structure not only mitigates costs and enhances supply chain stability but also fortifies its competitive edge in the burgeoning healthcare market. The company has also expanded its portfolio to include a diverse array of biochemical products, catering to various therapeutic areas such as anticoagulation, oncology, and anti-infectives. This diversification not only spreads risk but also captures a broader spectrum of revenue opportunities. Moreover, Dongcheng's keen eye for innovation has seen it invest heavily in research and development, ensuring that it remains at the cutting edge of biopharmaceutical advancements. Through this strategic orchestration of resources and innovation, Dongcheng continues to deepen its footprint in the global market, underscoring its reputation as a trusted and dynamic player in the pharmaceutical industry.

Intrinsic Value
18.38 CNY
Undervaluation 33%
Intrinsic Value
Price
Y
What is Intrinsic Value?

See Also

What is Yantai Dongcheng Biochemicals Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
2B CNY

Based on the financial report for Sep 30, 2024, Yantai Dongcheng Biochemicals Co Ltd's Additional Paid In Capital amounts to 2B CNY.

What is Yantai Dongcheng Biochemicals Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
13%

Over the last year, the Additional Paid In Capital growth was -20%. The average annual Additional Paid In Capital growth rates for Yantai Dongcheng Biochemicals Co Ltd have been -5% over the past three years , -3% over the past five years , and 13% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.